Sensei Biotherapeutics, Inc. Common Stock
SNSENASDAQUS Equity
$974.80▲ $37.72 (+3.87%)
Simulated priceTrack SNSE
Get earnings, price moves & breaking news on Telegram
24h▲ 3.9%
7d▲ 6907.9%
14d▲ 6907.9%
30d▲ 6907.9%
ytd▲ 9104.9%
1y▲ 11354.8%
🏦Market Cap
$211B
Large Cap
📈Revenue Growth (YoY)
+32.9%
High Growth
📊Gross Margin
43.6%
Healthy
💵FCF Margin
23.7%
Strong
⚖️P/S Ratio
12.9x
Elevated
Otter Score
72
Fair
Trading Snapshot
- Day Range
- $964.98 – $986.95
- 52-Week Range
- $792.72 – $1,368.74
- Volume
- $2.53B
- Avg Volume
- $2.03B
- Shares Outstanding
- 216.5M
- Next Earnings
- Dec 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $16.36B
- Last Q Revenue
- $3.68B
- P/E Ratio
- 30.6
- P/S Ratio
- 12.9x
- EPS (TTM)
- $31.86
- Dividend Yield
- 1.31%
- Dilution (1yr)
- −95.0%
Why Investors Own SNSE
- ✓High-growth profile — revenue up +32.9% YoY with expanding US Equity exposure.
- ✓Healthy economics — 44% gross margin and 24% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Sensei Biotherapeutics, Inc. Common Stock
SNSEFinancial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$22M▼ −29.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$20M▼ −17.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.3M▼ −95.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▲ +$1M YoY
StockOtter · stockotter.spaceAbout Sensei Biotherapeutics, Inc. Common Stock
A company profile for Sensei Biotherapeutics, Inc. Common Stock isn’t available yet — check back soon.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Fair
72/100
Analyst Price Target
ⓘAverage Target
$1,055.61
▲ +8.3% Upside
High Target$1,315.60
Low Target$855.69
Based on 36 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
Sensei Biotherapeutics, Inc. Common Stock tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift SNSE price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
Sensei Biotherapeutics, Inc. Common Stock announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.